Epithelial–Mesenchymal Transition Inhibition by Metformin Reduces Melanoma Lung Metastasis in a Murine Model

Researchers investigated the effects of metformin at epithelial-mesenchymal transition (EMT) in melanoma cell lines B16-F10 and A-375, in vitro, and the impact of EMT downregulation on melanoma progression in vivo.